Delivery Order SPE2DB20D1100-SPE2DB25FC4F6
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,100.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a performance period through May 1, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the...
This is a $3,004.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of March 12, 2025. The award is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for providing a range of...
This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,878.11, is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The order has an ultimate completion date of May 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,311.85, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, a for-profit organization, is the prime...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,917.12, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The award has an ultimate completion date of March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $6,491.68 and a period of performance through May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.64, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has a ceiling value of $6,653.87 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.47 firm fixed-price contract is to provide OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The order has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,042.97 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 29, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...